Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphaël Saffroy

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Chemistry and Laboratory Medicine|July 20, 2007
New perspectives and strategy research biomarkers for hepatocellular carcinomaRaphaël Saffroy, Patrick Pham, Maâmar Reffas, et al.
Current HIV Research|March 12, 2009
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control studyFranck Chiappini, Elina Teicher, Raphaël Saffroy, et al.
Annales De Pathologie|May 23, 2025
[An underdiagnosed orbital tumor?]Arnault Tauziède-Espariat, Marie Georges, Raphaël Saffroy, et al.
European Journal of Human Genetics : EJHG|May 29, 2002
Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinomaRaphaël Saffroy, Philippe Riou, Gwendoline Soler, et al.
World Neurosurgery|June 3, 2018
Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H MutationMorgan Tourne, Arnault Tauziède-Espariat, Edouard Dezamis, et al.
Addiction Biology|August 5, 2009
Association between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typologyAmine Benyamina, Raphaël Saffroy, Lisa Blecha, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2010
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosisMohamed Bouchahda, Abdoulaye Karaboué, Raphaël Saffroy, et al.
Biochemistry Research International|June 30, 2012
Mitochondrial roles and cytoprotection in chronic liver injuryDavide Degli Esposti, Jocelyne Hamelin, Nelly Bosselut, et al.
Addiction Biology|April 22, 2011
Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholismMarie-Charlotte Domart, Amine Benyamina, Antoinette Lemoine, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2017
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric studyMahamadou Tandia, Asma Mhiri, Bernard Paule, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Chemistry and Laboratory Medicine|July 20, 2007
New perspectives and strategy research biomarkers for hepatocellular carcinomaRaphaël Saffroy, Patrick Pham, Maâmar Reffas, et al.
Current HIV Research|March 12, 2009
Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control studyFranck Chiappini, Elina Teicher, Raphaël Saffroy, et al.
Annales De Pathologie|May 23, 2025
[An underdiagnosed orbital tumor?]Arnault Tauziède-Espariat, Marie Georges, Raphaël Saffroy, et al.
European Journal of Human Genetics : EJHG|May 29, 2002
Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinomaRaphaël Saffroy, Philippe Riou, Gwendoline Soler, et al.
World Neurosurgery|June 3, 2018
Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H MutationMorgan Tourne, Arnault Tauziède-Espariat, Edouard Dezamis, et al.
Addiction Biology|August 5, 2009
Association between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typologyAmine Benyamina, Raphaël Saffroy, Lisa Blecha, et al.
Cancer Chemotherapy and Pharmacology|April 3, 2010
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosisMohamed Bouchahda, Abdoulaye Karaboué, Raphaël Saffroy, et al.
Biochemistry Research International|June 30, 2012
Mitochondrial roles and cytoprotection in chronic liver injuryDavide Degli Esposti, Jocelyne Hamelin, Nelly Bosselut, et al.
Addiction Biology|April 22, 2011
Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholismMarie-Charlotte Domart, Amine Benyamina, Antoinette Lemoine, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2017
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric studyMahamadou Tandia, Asma Mhiri, Bernard Paule, et al.
Pageof 6